Cargando…
Evaluation of lamb colostrum supplements
INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, c...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786255/ https://www.ncbi.nlm.nih.gov/pubmed/32994358 http://dx.doi.org/10.1136/vr.105763 |
_version_ | 1783632588691210240 |
---|---|
author | Bond, Cherry |
author_facet | Bond, Cherry |
author_sort | Bond, Cherry |
collection | PubMed |
description | INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, colostrum replacers and supplements can be offered. Colostrum replacers should fully replace maternal colostrum, whereas colostrum supplements have been developed to provide exogenous immunoglobulins to neonates when natural concentrations are low and should contain a minimum of 3 g IgG/feed. METHODS: Fifteen different colostrum supplements were evaluated. For each product, two different batches were analysed for IgG content. RESULTS: Levels of IgG/feed ranged from 0.4 to 3.5 g. Products with the highest IgG levels were Lamaid (VetPlus), Colostro+ Lamb (Greencoat), Ovicol (Farmsense) and Shepherdess Lamb Colostrum (Provimi) averaging ≥3.0 g/feed. The remaining 11 products had IgG levels below 3 g IgG/feed, hence could be providing inadequate levels of IgG and potentially impacting on neonatal health. CONCLUSION: This study has shown great variability between the quality of commercially available colostrum supplements, so care must be taken when selecting products. |
format | Online Article Text |
id | pubmed-7786255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-77862552021-01-14 Evaluation of lamb colostrum supplements Bond, Cherry Vet Rec Electronic pages INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, colostrum replacers and supplements can be offered. Colostrum replacers should fully replace maternal colostrum, whereas colostrum supplements have been developed to provide exogenous immunoglobulins to neonates when natural concentrations are low and should contain a minimum of 3 g IgG/feed. METHODS: Fifteen different colostrum supplements were evaluated. For each product, two different batches were analysed for IgG content. RESULTS: Levels of IgG/feed ranged from 0.4 to 3.5 g. Products with the highest IgG levels were Lamaid (VetPlus), Colostro+ Lamb (Greencoat), Ovicol (Farmsense) and Shepherdess Lamb Colostrum (Provimi) averaging ≥3.0 g/feed. The remaining 11 products had IgG levels below 3 g IgG/feed, hence could be providing inadequate levels of IgG and potentially impacting on neonatal health. CONCLUSION: This study has shown great variability between the quality of commercially available colostrum supplements, so care must be taken when selecting products. BMJ Publishing Group 2020-11-28 2020-11-26 /pmc/articles/PMC7786255/ /pubmed/32994358 http://dx.doi.org/10.1136/vr.105763 Text en © British Veterinary Association 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Electronic pages Bond, Cherry Evaluation of lamb colostrum supplements |
title | Evaluation of lamb colostrum supplements |
title_full | Evaluation of lamb colostrum supplements |
title_fullStr | Evaluation of lamb colostrum supplements |
title_full_unstemmed | Evaluation of lamb colostrum supplements |
title_short | Evaluation of lamb colostrum supplements |
title_sort | evaluation of lamb colostrum supplements |
topic | Electronic pages |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786255/ https://www.ncbi.nlm.nih.gov/pubmed/32994358 http://dx.doi.org/10.1136/vr.105763 |
work_keys_str_mv | AT bondcherry evaluationoflambcolostrumsupplements |